Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Amyotrophic Lateral Sclerosis (ALS). Show all posts
Showing posts with label Amyotrophic Lateral Sclerosis (ALS). Show all posts
Monday, November 14, 2022

FDA Approves Relyvrio (sodium phenylbutyrate/taurursodiol) for Patients with Amyotrophic Lateral Sclerosis (ALS)

›
In continuation of my update on phenyl butyrate and taurursodiol .. Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”)...
Tuesday, June 14, 2022

FDA Approves Radicava ORS (edaravone) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

›
Mitsubishi Tanabe Pharma Corporation (MTPA)   announced the U.S. Food and Drug Administration (FDA)   approval of Radicava ORS (edaravone), ...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.